Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
ASO | -16.47% | $4.00B | -7.07% | 0.77% |
CVGW | -16.03% | $415.49M | -17.67% | 3.02% |
MGPI | -15.66% | $760.68M | -62.07% | 1.37% |
CBOE | -14.93% | $19.99B | +5.68% | 1.23% |
SUNS | -14.21% | $94.46M | +20.71% | 4.62% |
JBSS | -12.85% | $994.54M | -16.87% | 0.99% |
WHF | -12.78% | - | - | 15.93% |
HELE | -12.65% | $1.42B | -48.96% | 0.00% |
ZTO | -12.55% | $10.72B | -6.03% | 5.38% |
PRPO | -12.23% | $9.09M | +14.66% | 0.00% |
EBAY | -11.81% | $31.57B | +59.91% | 1.67% |
NUS | -10.75% | $309.20M | -65.67% | 3.63% |
FNKO | -10.75% | $758.15M | +106.31% | 0.00% |
TBBK | -10.68% | $2.41B | +30.51% | 0.00% |
VIPS | -10.65% | $5.65B | -22.14% | 3.33% |
LOGC | -10.52% | $177.42M | +59.39% | 0.00% |
ACGL | -10.13% | $33.93B | +22.06% | 0.00% |
ACHC | -9.99% | $4.17B | -47.68% | 0.00% |
IEP | -9.80% | $4.64B | -46.17% | 38.21% |
SMMT | -9.66% | $13.16B | +475.81% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
SNN | 0.01% | $10.44B | -12.53% | 3.14% |
ETD | -0.01% | $708.23M | -4.14% | 5.59% |
O | -0.01% | $45.22B | -12.28% | 6.04% |
BNED | 0.01% | $300.33M | -91.58% | 0.00% |
EQR | 0.01% | $25.41B | +7.75% | 4.03% |
UNM | -0.02% | $13.11B | +58.29% | 2.19% |
IGT | -0.02% | $3.51B | -32.43% | 4.64% |
DE | -0.02% | $110.96B | +5.71% | 1.48% |
LOPE | -0.03% | $4.69B | +28.22% | 0.00% |
NNN | -0.04% | $7.13B | -12.44% | 6.01% |
PAAS | 0.05% | $7.74B | +37.70% | 1.92% |
IDT | -0.05% | $1.15B | +40.30% | 0.44% |
LEVI | 0.05% | $6.99B | +10.82% | 2.86% |
IMAB | 0.05% | $80.87M | -48.78% | 0.00% |
ED | 0.05% | $30.54B | -3.79% | 3.76% |
WTS | -0.06% | $6.51B | -1.72% | 0.85% |
IMNN | -0.06% | $13.05M | +35.12% | 0.00% |
FDX | -0.06% | $65.21B | +8.92% | 2.01% |
TSLA | 0.06% | $1.27T | +80.34% | 0.00% |
MP | 0.06% | $3.22B | +11.02% | 0.00% |
Current Value
$658.601 Year Return
Current Value
$658.601 Year Return
SeekingAlpha
During the fourth quarter, the ClearBridge International Growth EAFE Strategy outperformed its MSCI EAFE Index benchmark. Click here to read the full commentary.
SeekingAlpha
Day One Biopharmaceuticals focuses on pediatric cancer treatments. Read more about the biotech's therapies and its prospects for 2025.
Yahoo
January 6, 2025Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that Tim Van Hauwermeiren, Chief Executive Officer, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025 at 9:45 a.m. PT. A live webcast of the presentation may be accessed on the Investors section of the argenx website at argenx.com/investors. A repl
Yahoo
As we enter January 2025, global markets are navigating a landscape marked by fluctuating consumer confidence and mixed economic indicators, with major U.S. stock indexes experiencing moderate gains amidst a holiday-shortened trading week. In this environment, identifying high-growth tech stocks requires careful consideration of factors such as innovation potential and market adaptability, particularly as the technology-heavy Nasdaq Composite continues to show resilience despite recent...
Yahoo
Argenx Se ( (ARGX) ) has provided an update. Argenx SE announced that Japan’s Ministry of Health, Labour and Welfare has approved VYVDURA for adults with chronic inflammatory demyelinating polyneuropathy (CIDP). This approval marks the first time the neonatal Fc receptor blocker has been authorized for CIDP treatment, providing patients with a convenient at-home self-injection option. The approval is based on the results of the ADHERE trial, which demonstrated significant clinical improvements i
Yahoo
VYVDURA® now approved for at-home self-injection in Japan for both generalized myasthenia gravis and CIDP argenx's VYVGART® and VYVDURA portfolio approved in Japan for three indications – first country globally with access across three indications December 27, 2024, 7:00 AM CET Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that Japan’s Ministry of
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
IONS | 34.74% | $5.28B | -37.50% | 0.00% |
ALNY | 33.71% | $30.69B | +23.06% | 0.00% |
IMVT | 31.77% | $3.45B | -44.57% | 0.00% |
RVMD | 28.66% | $7.62B | +46.60% | 0.00% |
APLS | 27.75% | $3.41B | -60.93% | 0.00% |
HALO | 26.05% | $6.72B | +53.35% | 0.00% |
BRZE | 25.65% | $4.41B | -20.12% | 0.00% |
ARWR | 25.44% | $2.30B | -49.25% | 0.00% |
KYMR | 24.73% | $2.47B | +35.74% | 0.00% |
ALT | 24.23% | $488.63M | -42.75% | 0.00% |
CLPT | 24.00% | $404.94M | +104.74% | 0.00% |
KVYO | 23.35% | $10.63B | +50.48% | 0.00% |
BIO | 23.17% | $9.57B | +7.28% | 0.00% |
RELY | 23.10% | $4.45B | +24.46% | 0.00% |
VRTX | 23.09% | $105.47B | -5.50% | 0.00% |
MCO | 23.08% | $82.05B | +19.23% | 0.75% |
SPGI | 22.75% | $149.79B | +10.46% | 0.76% |
GEV | 22.62% | $101.19B | +179.70% | 0.00% |
RELX | 22.40% | $86.03B | +12.69% | 1.70% |
ONIT | 22.28% | $234.56M | +3.98% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
FBT | 37.75% | $1.14B | 0.56% |
BBH | 35.90% | $399.16M | 0.35% |
IBB | 35.08% | $6.45B | 0.45% |
XBI | 31.70% | $6.43B | 0.35% |
PTH | 29.35% | $122.11M | 0.6% |
PBE | 29.00% | $254.47M | 0.58% |
GNOM | 26.27% | $71.69M | 0.5% |
IHE | 26.01% | $600.23M | 0.39% |
IXJ | 25.21% | $3.70B | 0.41% |
VHT | 24.78% | $16.71B | 0.1% |
PPH | 24.40% | $569.24M | 0.36% |
FHLC | 24.25% | $2.68B | 0.084% |
IYH | 24.16% | $3.13B | 0.39% |
HYDB | 23.25% | $1.19B | 0.35% |
FXH | 22.88% | $1.07B | 0.62% |
XLV | 22.21% | $37.73B | 0.09% |
FTHI | 21.68% | $1.10B | 0.75% |
XPH | 21.63% | $158.66M | 0.35% |
FLHY | 21.55% | $601.59M | 0.4% |
IMOM | 20.95% | $77.80M | 0.39% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -17.70% | $195.31M | 0.85% |
SEIX | -13.54% | $300.14M | 0.62% |
TPMN | -12.38% | $41.63M | 0.65% |
CCOR | -11.48% | $83.85M | 1.18% |
CTA | -10.05% | $497.20M | 0.76% |
TAIL | -10.01% | $65.56M | 0.59% |
MINT | -9.53% | $12.00B | 0.35% |
WEAT | -9.12% | $119.67M | 0.28% |
KRBN | -7.41% | $194.27M | 0.85% |
CLOI | -6.41% | $792.86M | 0.4% |
DBA | -4.58% | $790.77M | 0.93% |
GXC | -4.46% | $386.96M | 0.59% |
CONY | -4.19% | $1.06B | 1.01% |
SHYD | -3.94% | $311.71M | 0.35% |
CHIQ | -3.69% | $203.09M | 0.65% |
FLCH | -3.60% | $141.60M | 0.19% |
CXSE | -3.52% | $366.89M | 0.32% |
OWNS | -3.28% | $126.27M | 0.3% |
AGZD | -3.05% | $142.77M | 0.23% |
PGJ | -3.03% | $136.86M | 0.67% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
YEAR | -0.05% | $1.18B | 0.25% |
LIT | -0.13% | $1.06B | 0.75% |
UUP | 0.22% | $607.07M | 0.77% |
UDN | 0.30% | $47.44M | 0.78% |
IYM | -0.31% | $509.34M | 0.39% |
BTF | -0.40% | $36.24M | 1.24% |
XHLF | -0.61% | $939.87M | 0.03% |
COPX | 0.62% | $2.65B | 0.65% |
BSCP | -0.63% | $3.98B | 0.1% |
CPER | -0.76% | $150.48M | 0.97% |
UNG | 0.78% | $790.37M | 1.06% |
SHV | 0.80% | $19.10B | 0.15% |
FXI | -0.89% | $6.95B | 0.74% |
EPU | -1.17% | $72.98M | 0.59% |
DFNM | 1.21% | $1.44B | 0.17% |
XLB | 1.31% | $5.21B | 0.09% |
SLVP | 1.46% | $221.85M | 0.39% |
BITO | -1.61% | $2.33B | 0.95% |
CORN | -1.73% | $63.58M | 0.2% |
TBIL | 1.75% | $4.78B | 0.15% |